688356 Stock Overview
Jenkem Technology Co., Ltd. develops and manufactures polyethylene glycol derivative (PEG) products in China.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 6/6 |
Past Performance | 1/6 |
Financial Health | 5/6 |
Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Jenkem Technology Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥112.64 |
52 Week High | CN¥256.50 |
52 Week Low | CN¥111.88 |
Beta | 0.73 |
1 Month Change | -10.48% |
3 Month Change | -31.84% |
1 Year Change | -43.20% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -17.68% |
Recent News & Updates
Recent updates
Shareholder Returns
688356 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -5.1% | -0.8% | -0.2% |
1Y | -43.2% | 11.4% | -1.9% |
Return vs Industry: 688356 underperformed the CN Pharmaceuticals industry which returned 11.4% over the past year.
Return vs Market: 688356 underperformed the CN Market which returned -1.9% over the past year.
Price Volatility
688356 volatility | |
---|---|
688356 Average Weekly Movement | 4.5% |
Pharmaceuticals Industry Average Movement | 4.6% |
Market Average Movement | 4.9% |
10% most volatile stocks in CN Market | 8.8% |
10% least volatile stocks in CN Market | 3.0% |
Stable Share Price: 688356 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: 688356's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 252 | Xuan Zhao | https://www.jenkem.com |
Jenkem Technology Co., Ltd. develops and manufactures polyethylene glycol derivative (PEG) products in China. The company offers branched, linear, homobifunctional, heterobifunctional, multi-arm homofunctional, multi-arm heterofunctional, monodisperse / discrete, and biodegradable PEG products. It also provides PEGylation services and testing services for peptides, proteins, enzymes, small molecules, and RNA.
Jenkem Technology Co., Ltd. Fundamentals Summary
688356 fundamental statistics | |
---|---|
Market Cap | CN¥6.79b |
Earnings (TTM) | CN¥181.58m |
Revenue (TTM) | CN¥399.18m |
37.4x
P/E Ratio17.0x
P/S RatioIs 688356 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
688356 income statement (TTM) | |
---|---|
Revenue | CN¥399.18m |
Cost of Revenue | CN¥71.66m |
Gross Profit | CN¥327.52m |
Other Expenses | CN¥145.94m |
Earnings | CN¥181.58m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 3.01 |
Gross Margin | 82.05% |
Net Profit Margin | 45.49% |
Debt/Equity Ratio | 0.4% |
How did 688356 perform over the long term?
See historical performance and comparison